Sampre Nutritions Shares Jump 5% on Strategic Egypt Expansion Plan
In a significant market development, shares of Sampre Nutritions Limited, a small-cap confectionery manufacturer trading under ₹50, witnessed a robust surge of 5.24% on Friday, February 6. The stock price climbed to ₹24.32 at the Bombay Stock Exchange (BSE), up from its opening price of ₹23.50, following an important capital expenditure update regarding its subsidiary's operations in Egypt.
Egypt Industrial Land Agreement Fuels Growth Ambitions
The catalyst for this upward movement was a formal exchange filing made by the company during market hours. Sampre Nutrition Holding Limited, a wholly-owned subsidiary of Sampre Nutritions Limited, has entered into a Land Purchase and Allocation Agreement with Orascom Industrial Parks, Egypt, effective February 1, 2026.
This strategic agreement is designed to establish comprehensive industrial operations focused on food processing and confectionery production. Orascom Industrial Parks has officially approved the sale and allocation of a substantial 30,000-square-meter industrial land parcel within its designated park area.
This new facility is anticipated to significantly enhance Sampre Nutritions' manufacturing capabilities and provide substantial support for the company's long-term growth strategy in international markets.
Impressive Financial Performance in Q2FY26
Complementing this expansion news, Sampre Nutritions has reported exceptionally strong financial results for the second quarter of fiscal year 2026. The company achieved revenue from operations of ₹9.99 crore, representing a substantial 37.5% increase compared to ₹7.27 crore in the same quarter of the previous fiscal year.
Even more remarkable was the net profit performance, which reached ₹89.55 lakh during Q2FY26. This figure marks an extraordinary six-fold year-over-year growth from the ₹12.45 lakh net profit recorded in Q2FY25, demonstrating significant operational efficiency and profitability improvement.
Recent Corporate Developments and Strategic Partnerships
The company has been actively engaged in several important corporate actions throughout recent months:
- November 5, 2025: The Board of Directors approved the issuance of equity shares to promoters Brahma Gurbani and Meera Gurbani through conversion of existing unsecured loans on a preferential basis. This included the allotment of 17.70 lakh equity shares with a face value of ₹5 at ₹42 per share, converting unsecured loans totaling ₹7.43 crore.
- November 17, 2025: The Board sanctioned the issuance of 43,693,710 bonus equity shares, each with a face value of ₹5, in a favorable 1:1 ratio to eligible shareholders.
- December 22, 2025: Approval was granted for the conversion of 13 Foreign Currency Convertible Bonds (FCCBs), resulting in the allotment of 7,621,493 equity shares at a conversion price of ₹14.96 per share.
In another strategic move, Sampre Nutritions recently finalized a manufacturing agreement with Reliance Consumer Products Limited (RCPL) to produce and supply nutraceutical and food products. This partnership is projected to generate annual revenues between ₹12 to 15 crores over a three-year period, according to company statements.
The combination of international expansion, strong financial performance, and strategic corporate developments has positioned Sampre Nutritions as a company demonstrating both growth ambition and execution capability in the competitive food processing sector.
